The Effects of Hyperbaric Oxygen Therapy (HBOT) on Acute Thermal Burns
NCT ID: NCT00824551
Last Updated: 2009-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
80 participants
INTERVENTIONAL
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Determine the effects of HBOT on burns conversion for patients who have fresh thermal burns injury using the LDI.
* Objectively determine the proportion of burns conversion in areas of partial thickness burns for early thermal burns injury in both arms of the RCT.
* Study the effects of HBOT on immunological markers IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α and TGF-β ( comparison between both arms and 2 assessment points).
* Study the effect of HBOT on haematological markers including procalcitonin ,albumin, lymphocyte counts, neutrophil count, and macrophage count.
* Study the effects of HBOT on histology specimens in quantifying P53 protein, leukocyte and macrophage infiltration, burns depth assessment and vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) .
* Study the effects of HBOT on bacteriology of tissue culture in areas of deep dermal burns.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing
NCT01605110
Effect of Extracorporeal Shock Wave Therapy for Burn Scar Charateristics
NCT04187586
Research on the Key Technology of Burn Wound Treatment
NCT03279549
The Effect of Extracorporeal Shock Wave Therapy in the Treatment of Post Burn Scars
NCT04558944
Carbon Dioxide Laser Treatment in Burn-related Scarring
NCT03433664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyperbaric Oxygen Therapy
2 HBOT treatments
Hyperbaric Oxygen Therapy
2 sessions of HBOT ( HDMC 14)
2
Standard care and treatment
Standard care
Patient will undergo standard care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric Oxygen Therapy
2 sessions of HBOT ( HDMC 14)
Standard care
Patient will undergo standard care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Less than 24 hours from time of injury.
* No inhalational injury (Nasoendoscopy and bronchoscopic diagnosis by burns centre medical team/ department of emergency medicine in SGH).
* Age 21 years old and above and less than 60 years old.
* Not intubated and not on inotropic support.
* Understands and agrees to informed consent (approved by IRB SGH).
Exclusion Criteria
* Medications: Bleomycin, Cis-platin, Doxorubicin, Disulfiram (Chemotherapy)
* Acute uncontrolled medical condition or significant medical condition (eg. Cerebrovascular accident, diabetic ketoacidosis, severe hypertensive 180/ 110 mmHg, end stage renal failure, chest pain, bleeding gastrointestinal tract, coma and acute asthma attack)
* Other surgical emergencies (eg. open fractures, compartment syndrome and acute abdomen)
21 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
republic of singapore navy and singapore general hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore General Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.